Novavax research chief Gregory Glenn told Reuters the company will start much larger late-stage clinical trials soon and could potentially glean enough data to obtain regulatory approvals as early as December.
Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più:
No thanks I will takes my chances with covid
WJGunning Distraction from miserable failure.
Nothing as reassuring as a rushed vaccine. Wonder how many people will die from it.